Skip to main content

Advertisement

Log in

Cytoreductive Surgery and Peritonectomy Procedures

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has become widely accepted as an effective method of treating peritoneal metastases (PM) from various cancers. CRS performed with the goal of removing all the macroscopic disease and comprises of peritonectomy procedures and visceral resections. CRS is a technically challenging surgery that requires a considerable amount of skill and appropriate patient selection. This article is a review of the techniques and current recommendations for performing CRS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  1. Lambert LA (2015) Looking up: Recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin 65(4):284–298

    Article  PubMed  Google Scholar 

  2. Sugarbaker PH (2015) Management of peritoneal metastases - Basic concepts. J BUON 20(Suppl 1):S2–11

    PubMed  Google Scholar 

  3. Healy JC, Reznek RH (1998) The peritoneum, mesenteries and omenta: normal anatomy and pathological processes. Eur Radiol 8:886–900

    Article  CAS  PubMed  Google Scholar 

  4. Meyers MA, Oliphant M, Berne AS, Feldberg MA (1987) The peritoneal ligaments and mesenteries: pathways of intraabdominal spread of disease. Radiology 163:593–604

    Article  CAS  PubMed  Google Scholar 

  5. Levy AD, Arnáiz J, Shaw JC, Sobin LH (2008) From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics 28:583–607 quiz 621-622

    Article  PubMed  Google Scholar 

  6. Sheth S, Horton KM, Garland MR, Fishman EK (2003) Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis. Radiographics 23:457–473

    Article  PubMed  Google Scholar 

  7. Oliphant M, Berne AS (1982) Computed tomography of the subperitoneal space: demonstration of direct spread of intraabdominal disease. J Comput Assist Tomogr 6:1127–1137

    Article  CAS  PubMed  Google Scholar 

  8. Karaosmanoglu D, Karcaaltincaba M, Oguz B, Akata D, Ozmen M, Akhan O (2009) CT findings of lymphoma with peritoneal, omental and mesenteric involvement: peritoneal lymphomatosis. Eur J Radiol 71:313–317

    Article  PubMed  Google Scholar 

  9. Sugarbaker PH (1994) Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 219(2):109–111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lengyel E (2010) Ovarian Cancer Development and Metastasis. Am J Pathol 177(3):1053–1064

    Article  PubMed  PubMed Central  Google Scholar 

  11. Le O (2013) Patterns of peritoneal spread of tumor in the abdomen and pelvis. World J Radiol 5(3):106–112. doi:10.4329/wjr.v5.i3.106

    Article  PubMed  PubMed Central  Google Scholar 

  12. Bao P, Bartlett D (2009) Surgical techniques in visceral resection and peritonectomy procedures. Cancer J 15(3):204–211

    Article  PubMed  Google Scholar 

  13. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29–42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH (2003) Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 22:465–472

    Article  PubMed  Google Scholar 

  15. Sugarbaker PH (2002) The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. Eur J Surg Oncol 28:443–446

    Article  CAS  PubMed  Google Scholar 

  16. Sugarbaker P (2013) Cytoreductive surgery using peritonectomy and visceral resections for peritoneal surface malignancy. Transl Gastrointest Cancer 2(2):54–74

    Google Scholar 

  17. Mohamed F, Cecil T, Moran B, Sugarbaker P (2011) A new standard of care for the management of peritoneal surface malignancy. Curr Oncol 18(2):e84–e96

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374

    Article  CAS  PubMed  Google Scholar 

  19. Sugarbaker PH (2009) Epithelial appendiceal neoplasms. Cancer J 15:225–235

    Article  PubMed  Google Scholar 

  20. Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ (1997) Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol 2:197–226

    CAS  PubMed  Google Scholar 

  21. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, Lorimier G, Dubè P, Glehen O (2009) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28(1):63–68

    Article  PubMed  Google Scholar 

  22. Yan TD, Deraco M, Baratti D, et al. (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237–6242

    Article  PubMed  Google Scholar 

  23. Verwaal VJ, Kusamura S, Baratti D, et al. (2008) The eligibility for local-regional treatment of peritoneal surface malignancy. J Surg Oncol 98:220–223

    Article  PubMed  Google Scholar 

  24. Yan TD, Morris DL, Kusamura S, et al. (2008) Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Surg Oncol 98:224–227

    Article  PubMed  Google Scholar 

  25. Coakley FV, Choi PH, Gougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499

    Article  PubMed  Google Scholar 

  26. Esquivel J, Chua TC, Stojadinovic A, et al. (2010) Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol 102:565–570

    Article  CAS  PubMed  Google Scholar 

  27. Low RN, Barone RM, Lee MJ (2013) Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC. Ann Surg Oncol 20(4):1074–1081

    Article  PubMed  Google Scholar 

  28. Torkzad MR, Casta N, Bergman A, Ahlström H, Påhlman L, Mahteme H (2015) Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist. J Surg Oncol 111(6):746–751

    Article  CAS  PubMed  Google Scholar 

  29. Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: Enhanced CT vs. PET/CT. Abdom Imaging 33:87–89

    Article  PubMed  Google Scholar 

  30. Jacquet P, Jelinek JS, Chang D, et al. (1995) Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181:530–538

    CAS  PubMed  Google Scholar 

  31. Yan TD, Haveric N, Carmignani CP, et al. (2005) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103:839–849

    Article  PubMed  Google Scholar 

  32. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Kluwer Academic Publishers, Boston, pp. 359–374

    Chapter  Google Scholar 

  33. Goéré D, Souadka A, Faron M, Cloutier AS, Viana B, Honoré C, Dumont F, Elias D (2015) Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol 22(9):2958–2964

    Article  PubMed  Google Scholar 

  34. Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P, Montori G, Ansaloni L (2015) Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis. Eur J Surg Oncol 41(7):911–919

    Article  CAS  PubMed  Google Scholar 

  35. Bakrin N, JM B, Decullier E, JM C, Msika S, Lorimier G, Abboud K, Meeus P, Ferron G, Quenet F, Marchal F, Gouy S, Morice P, Pomel C, Pocard M, Guyon F, Porcheron J, Glehen O, FROGHI (FRench Oncologic and Gynecologic HIPEC) Group (2013) Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39(12):1435–1443

    Article  CAS  PubMed  Google Scholar 

  36. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, et al. (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456

    Article  PubMed  Google Scholar 

  37. Sugarbaker PH (2013) Cytoreductive surgery and perioperative chemotherapy: Textbook and video atlas. Cine-Med Publishing, Connecticut

    Google Scholar 

  38. Sugarbaker PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43:15–25

    Article  Google Scholar 

  39. Glehen O, FN G, Arvieux C, Cotte E, Boutitie F, Mansvelt B, JM B, Lorimier G, Quenet F, Elias D, Association Française de Chirurgie (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9):2370–2377

    Article  PubMed  Google Scholar 

  40. Glehen O, Mohamed F, Sugarbaker PH (2004) Incomplete Cytoreduction in 174 Patients with Peritoneal Carcinomatosis From Appendiceal Malignancy. Ann Surg 240(2):278–285

    Article  PubMed  PubMed Central  Google Scholar 

  41. Dayal S, Taflampas P, Riss S, Chandrakumaran K, Cecil TD, Mohamed F, Moran BJ (2013) Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum 56(12):1366–1372

    Article  PubMed  Google Scholar 

  42. González-Moreno S, Ortega-Pérez G, González-Bayón L (2009) Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Surg Oncol 100(4):287–292

    Article  PubMed  Google Scholar 

  43. Passot G, Vaudoyer D, Cotte E, You B, Isaac S, Noël Gilly F, Mohamed F, Glehen O (2012) Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis. Ann Surg 256(1):125–129

    Article  PubMed  Google Scholar 

  44. Honoré C, Souadka A, Goéré D, Dumont F, Deschamps F, Elias D (2012) HIPEC for peritoneal carcinomatosis: does an associated urologic procedure increase morbidity? Ann Surg Oncol 19(1):104–109

    Article  PubMed  Google Scholar 

  45. Glehen O, Beaujard AC, Arvieux C, Huber O, Gilly FN (2002) Peritoneal carcinomatosis. Surgical treatment, peritonectomy and intraperitoneal chemohyperthermia. Gastroenterol Clin Biol 26:210–215

    PubMed  Google Scholar 

  46. Elias DM, Ouellet JF (2001) Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. Surg Oncol Clin N Am 10:915–933

    CAS  PubMed  Google Scholar 

  47. Elias D, Benizri E, Pocard M, Ducreux M, Boige V, Lasser P (2006) Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 32:632–636

    Article  CAS  PubMed  Google Scholar 

  48. Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, Hay JM, Flamant Y, Msika S (2007) Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 245:597–603

    Article  PubMed  PubMed Central  Google Scholar 

  49. Cotte E, Passot G, Gilly F-N, Glehen O (2010) Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2(1):31–35

    Article  PubMed  PubMed Central  Google Scholar 

  50. Sugarbaker PH (1994) Dissection by electrocautery with a ball tip. J Surg Oncol 56:246–248

    Article  CAS  PubMed  Google Scholar 

  51. Sugarbaker PH (1996) Laser-mode electrosurgery. Cancer Treat Res 82:375–385

    Article  CAS  PubMed  Google Scholar 

  52. Zappa L, Sugarbaker PH (2007) Compartment syndrome of the leg associated with lithotomy position for cytoreductive surgery. J Surg Oncol 96:619–623

    Article  PubMed  Google Scholar 

  53. de Lima VV, Sugarbaker PH (2003) Xiphoidectomy. Gastric Cancer 6:127–129

    Google Scholar 

  54. Vazquez Vde L, Sugarbaker PH (2003) Total anterior parietal peritonectomy. J Surg Oncol 83:261–263

    Article  PubMed  Google Scholar 

  55. Dagbert F, Passot G, Glehen O, Bakrin N (2015) Glisson capsulectomy for extensive superficial liver involvement in peritoneal carcinomatosis (with video). J Visc Surg 152(5):332–333

    Article  CAS  PubMed  Google Scholar 

  56. Deslauriers N, Olney H, Younan R (2011) Splenectomy revisited in 2011: Impact on hematologic toxicities while performing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Gastrointest Oncol 2(2):61–63

    PubMed  PubMed Central  Google Scholar 

  57. Becher RD, Shen P, Stewart JH, Russell G, Bradley JF, Levine EA (2011) Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy. J Gastrointest Oncol 2(2):70–76

    PubMed  PubMed Central  Google Scholar 

  58. Sugarbaker PH (2010) Pont hepatique (hepatic bridge), an important anatomic structure in cytoreductive surgery. J Surg Oncol 101:251–252

    Article  PubMed  Google Scholar 

  59. Chang S-J, Bristow RE (2015) Surgical technique of en bloc pelvic resection for advanced ovarian cancer. J Gynecol Oncol 26(2):155

    Article  PubMed  PubMed Central  Google Scholar 

  60. Bijelic L, Sugarbaker PH (2008) Cytoreduction of the small bowel surfaces. J Surg Oncol 97:176–179

    Article  PubMed  Google Scholar 

  61. Pathiraja PNJ, Garruto-Campanile R, Tozzi R (2013) Diaphragmatic Diaphragmatic peritonectomy versus full thickness diaphragmatic resection and pleurectomy during cytoreduction in patients with ovarian cancer. Int J Surg Oncol 2013:876150

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Hertel H, Diebolder H, Herrmann J, Köhler C, Kühne-Heid R, Possover M, Schneider A (2001) Is the decision for colorectal resection justified by histopathologic findings: a prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol; 83(3):481–484. PMID:11733959

  63. Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL, Perrin LC, Ward BG, Crandon AJ (2001) Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 83(1):115–120

    Article  CAS  PubMed  Google Scholar 

  64. Yildirim Y, Ertas IE, Nayki U, Ulug P, Nayki C, Yilmaz I, Gultekin E, Dogan A, Aykas A, Ulug S, Ozdemir A, Solmaz U (2014) En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer. Eur J Gynaecol Oncol 35(4):400–407

    CAS  PubMed  Google Scholar 

  65. Mourton SM, Temple LK, Abu-Rustum NR, Gemignani ML, Sonoda Y, Bochner BH, Barakat RR, Chi DS (2005) Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 99(3):608–614

    Article  PubMed  Google Scholar 

  66. Sonnendecker EW, Beale PG (1989) Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma. Int Surg 74(1):10–12

    CAS  PubMed  Google Scholar 

  67. Sugarbaker PH (2015) Avoiding Diverting Ileostomy in Patients Requiring Complete Pelvic Peritonectomy. Ann Surg Oncol 2015

  68. Sugarbaker PH (2002) Cytoreduction including total gastrectomy for pseudomyxoma peritonei. Br J Surg 89(2):208–212

    Article  CAS  PubMed  Google Scholar 

  69. Piso P, Slowik P, Popp F, Dahlke MH, Glockzin G, Schlitt HJ (2009) Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 16(8):2188–2194

    Article  PubMed  Google Scholar 

  70. Deraco M, Baratti D, Kusamura S, Laterza B, Balestra MR (2009) Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol 100(4):321–328. doi:10.1002/jso.21388

    Article  PubMed  Google Scholar 

  71. Foster JM, Gupta PK, Carreau JH, Grotz TE, Blas JV, Gatalica Z, Nath S, Loggie BW (2012) Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei. Am Surg 78(2):171–177

    PubMed  Google Scholar 

  72. Doud AN, Randle RW, Clark CJ, Levine EA, Swett KR, Shen P, Stewart JH, Votanopoulos KI (2015) Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2(5):1645–1650

    Article  Google Scholar 

  73. Schwarz L, Votanopoulos K, Morris D, Yonemura Y, Deraco M, Piso P, Moran B, Levine EA, Tuech JJ (2016) Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter Study. Ann Surg 263(2):369–375

    Article  PubMed  Google Scholar 

  74. Mahdi H, Rose PG, Gonzalez S, DeBernardo R, Knight J, Michener C, Moselmi-Kebria M (2015) Postoperative Complications After Distal Pancreatectomy Performed During Cytoreductive Surgery for Gynecologic Malignancies. Int J Gynecol Cancer 25(6):1128–1133

    Article  PubMed  Google Scholar 

  75. Bacalbasa N, Dima S, Brasoveanu VDavid L, et al. (2015) Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit. World J Surg Oncol 13:235

    Article  PubMed  PubMed Central  Google Scholar 

  76. Gasparri ML, Grandi G, Bolla D, Gloor B, Imboden S, Panici PB, Mueller MD, Papadia A (2015) Hepatic resection during cytoreductive surgery for primary or recurrent ovarian cancer. J Cancer Res Clin Oncol 1–12

  77. Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. (2003) Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863–869

    Article  CAS  PubMed  Google Scholar 

  78. Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FAN (2004) Toxicity of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 85:61–67

    Article  PubMed  Google Scholar 

  79. Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, et al. (2006) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 106:1144–1153

    Article  PubMed  Google Scholar 

  80. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, et al. (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6:790–796

    Article  CAS  PubMed  Google Scholar 

  81. Franko J, Gusani NJ, Holtzman MP, Ahrendt SA, Jones HL, HJ Z 3rd, DL B (2008) Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol 15(11):3065–3072

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olivier Glehen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mehta, S.S., Bhatt, A. & Glehen, O. Cytoreductive Surgery and Peritonectomy Procedures. Indian J Surg Oncol 7, 139–151 (2016). https://doi.org/10.1007/s13193-016-0505-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-016-0505-5

Keywords

Navigation